Yining Xu (ADDB, LDRI) - April 27 - 16.30 - Teams Event

Peptide-loaded nanoparticle oral delivery strategies towards diabetes treatment

Promoters: Ana  Beloqui  -Véronique Préat

Related papers

• Xu Y., Shrestha N., Préat V., Beloqui A. Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems. Journal of Controlled Release (2020). In press
• Xu Y., van Hul M., Suriano F., Préat V., Cani P.D., Beloqui A. A novel strategy for oral peptide delivery in incretin-based diabetes treatment. Gut 69 (2020) 911-919.
• Xu Y., Carradori D., Alhouayek M., Muccioli G.G., Cani P.D., Préat V., Beloqui A. Size effect on lipid nanocapsules-mediated GLP-1 secretion from enteroendocrine L cells. Molecular Pharmaceutics 15 (2018) 108-115.